Fluvac Innovator EHV-4/1
For vaccination of healthy
horses as an aid in the prevention of respiratory disease caused by EHV-1 and
EHV-4 viruses and equine influenza due to types A1 and A2
viruses (now includes KY 97).
Fluvac Innovator EHV-4/1 Plus
is a killed virus vaccine consisting of equine herpesvirus 1 and equine
herpesvirus 4 (both forms of equine rhinopneumonitis virus), and types
A1 and A2 (Kentucky 97) equine influenza viruses. Fluvac
Innovator EHV-4/1 Plus is grown and prepared on a stable cell line
The MetaStim® adjuvant is added to enhance the immune
response and to promote the proper rate of absorption following inoculation.
Formalin, Thimerosal, neomycin, Polymyxin B and amphotericin B added as
Administration and Dosage:
one 1 ml dose intramuscularly using aseptic technique. Administer a second dose
2 to 4 weeks after the first dose. A 1 ml booster should be given annually, when
exposure is likely, or at any time epidemic conditions exist. Mild exercise to
promote absorption is recommended for one week after injection. Shake well
Store in the dark at 2° to 7°C
(35° to 45°F). Avoid freezing. Shake well. In some instances, transient local
reactions may occur at the injection site. Do not vaccinate within 21 days
before slaughter. In case of anaphylactoid reaction, administer epinephrine. For
veterinary use only.
Single dose vial with 20x1 ˝”
needle, or a multi-dose 10 ml 10 dose vial.